Skip to main content

Search every trial. Check your eligibility. Apply.

1

Search all recruiting trials in the US

Every actively recruiting trial across all 50 states, synced daily from ClinicalTrials.gov. Search by condition, treatment, NCT ID, or location and filter by distance from you.

Type 2 diabetes

● Recruiting · NCT05481919

Semaglutide in Adults With Early Type 2 Diabetes
4.2 mi

● Recruiting · NCT06120344

Continuous Glucose Monitoring & Lifestyle Coaching
11 mi

● Recruiting · NCT05933172

Oral Insulin Capsule vs. Basal Insulin
23 mi

Example trials for illustration only; they may not be real or currently recruiting.

2

Add your health record

We read each trial's eligibility criteria against your record and show you which ones you meet.

Upload your records

Drop in visit summaries, lab reports, or discharge notes. We pull out conditions, medications, labs, and procedures.

We find your records for you

Coming soon

No logins to remember, no list of every doctor you've seen. Verify your identity, give consent, and we retrieve your records from health systems nationwide through TEFCA and FHIR.

Connect a patient portal

Coming soon

Sign in to MyChart (Epic), athenahealth, or your health system's portal and we sync your records automatically.

Your records stay in your control. Nothing is shared with a trial team unless you apply.

Osimertinib Plus Chemotherapy in EGFR-Mutated Advanced NSCLC

Example eligibility5 of 6 criteria answered
✓Stage IIIB–IV non-small cell lung cancerstaged in your oncology note, Jan 2026
✓EGFR exon 19 deletion or L858R mutationfound in your pathology report, Dec 2025
✓ECOG performance status 0–1recorded at your visit, May 2026
✓Adequate organ function (ANC ≥ 1,500/µL, platelets ≥ 100k)computed from your CBC panel, Jun 2026
✓No prior third-generation EGFR inhibitorno osimertinib in your medication history
?No untreated brain metastasesyour last brain MRI is 14 months old — a current scan is needed
3

Apply, or reach out directly

Apply and the care team running the trial reviews your profile and follows up. Prefer to make first contact yourself? Every trial lists the study team's email.

We're still bringing care teams onto the platform. If a trial's team isn't on Saturn yet, they won't see your profile. Emailing them directly is the surest route, and you can customize the email before sending.

Or contact the study team

Email the site directlyWe draft it from your profile. Edit anything before you send.
Toj.alvarez@stanfordhealth.orgSubjectInterest in NCT05481919 — Semaglutide in Early Type 2 Diabetes

Hi Dr. Alvarez,

I'm a 47-year-old with type 2 diabetes (diagnosed 2023) living in Menlo Park, CA. I'm not on insulin, and I'd like to be considered for your trial. I'm happy to get a current HbA1c if needed.

Could you let me know the next step?

Thank you,
Alex Rivera

Drafted from your profile · editableEdit & send →